Xianle Health Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
300791SZSE
Notice on the Resumption of Conversion for Xianle Convertible Bonds
✨ AI Summary
This announcement informs that the Xianle Convertible Bonds (code: 123113) will resume conversion on June 5, 2026, after a temporary suspension from May 28 to June 4, 2026. This suspension was due to the implementation of the 2025 equity distribution. Bondholders are advised to take note of this change.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.